UMED fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Unité de Fabrication de Médicaments is a holding company, which engages in the manufacture of pharmaceutical products. It offer generic drugs such as furoxem, bupicaine, mydricol, rachianestehesie,doperan, furoxem, levoject, ketomed, amoxil, ampicil, cefaxone, oflocol, and cefazol. The company was founded by Ridha Charfeddine in 1989 and is headquartered in Sousse, Tunisia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
UMED does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company